Q32 Bio, Inc. (QTTB)
16.34
+0.37
(+2.32%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -754.8% |
| June 30, 2023 | -181.2% |
| March 31, 2023 | -232.0% |
| December 31, 2022 | -4.28K% |
| September 30, 2022 | -4.21K% |
| June 30, 2022 | -3.63K% |
| March 31, 2022 | |
| December 31, 2021 | -4.19K% |
| September 30, 2021 | -1.83K% |
| June 30, 2021 | -1.39K% |
| March 31, 2021 | -3.66% |
| December 31, 2020 | -3.04K% |
| Date | Value |
|---|---|
| September 30, 2020 | -4.98K% |
| June 30, 2020 | -6.23K% |
| March 31, 2020 | -6.01K% |
| December 31, 2019 | -4.29K% |
| September 30, 2019 | -6.72K% |
| June 30, 2019 | -6.70K% |
| March 31, 2019 | -8.83K% |
| December 31, 2018 | -1.57K% |
| September 30, 2018 | -883.1% |
| June 30, 2018 | -890.8% |
| March 31, 2018 | -905.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Rallybio Corp. | -- |
| Beam Therapeutics, Inc. | -25.04K% |
| C4 Therapeutics, Inc. | -355.9% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 103.3% |
| Return on Assets | 46.25% |
| Return on Invested Capital | 72.33% |
| Return on Net Operating Assets | 420.9% |